Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-24

Clinical Trial Update: Use of Tocilizumab for Rheumatoid Arthritis (RA) in Daily Routine

View source ↗

Summary

A completed clinical trial evaluating the use of tocilizumab for rheumatoid arthritis in routine clinical practice has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2016-10-24